What is the likelihood of a negative ultrasound but a positive HIDA (hepatobiliary iminodiacetic acid) scan in a patient with suspected gallbladder disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Likelihood of Negative Ultrasound with Positive HIDA Scan in Suspected Gallbladder Disease

When ultrasound is negative or equivocal for gallbladder disease, HIDA scan can be positive in a substantial proportion of patients, particularly in functional gallbladder disorder and acute cholecystitis, making it a valuable next-step diagnostic tool despite ultrasound's role as first-line imaging.

Understanding the Diagnostic Sequence

The ACR Appropriateness Criteria clearly establish that ultrasound is the initial imaging test of choice for suspected biliary disease, with 96% accuracy for detecting gallstones 1. However, ultrasound has important limitations:

  • Sensitivity for acute cholecystitis: 88% (95% CI: 74%-100%)
  • Specificity for acute cholecystitis: 80% (95% CI: 62%-98%) 1

In contrast, HIDA scan (cholescintigraphy) demonstrates superior diagnostic performance:

  • Sensitivity for acute cholecystitis: 97% (95% CI: 96%-98%)
  • Specificity for acute cholecystitis: 90% (95% CI: 86%-95%) 1

When HIDA Scan Adds Diagnostic Value After Negative Ultrasound

Acute Cholecystitis Scenario

When ultrasound is negative or equivocal but clinical suspicion remains high, HIDA scan frequently identifies acute cholecystitis that ultrasound missed. Historical data shows:

  • In one study, ultrasound correctly diagnosed acute cholecystitis in 21 of 23 proven cases, missing 2 cases that showed only chronic changes 2
  • HIDA scan was diagnostic in 19 of these 23 cases 2
  • The 9% sensitivity gap between ultrasound (88%) and HIDA (97%) represents patients with negative ultrasound but positive HIDA 1

Functional Gallbladder Disorder (Chronic Acalculous Biliary Pain)

This is where the discrepancy is most clinically relevant. HIDA scan with CCK stimulation is specifically indicated when ultrasound is normal but patients have biliary-type pain meeting Rome III criteria 3, 1.

Recent data from 2026 reveals important findings:

  • Among patients with normal HIDA scans, 83.3% still had chronic cholecystitis on pathology, 44.4% had cholesterolosis, and 26.3% had cholelithiasis 4
  • HIDA scan sensitivity was only 80.4% with specificity of 33.3% in this surgical cohort 4
  • The benefit of HIDA appears greatest when there are positive symptoms AND negative ultrasound findings 4

Clinical Algorithm for Negative Ultrasound

When ultrasound is negative or equivocal:

  1. If acute cholecystitis is suspected (fever, elevated WBC, RUQ tenderness):

    • HIDA scan is the appropriate next test 1
    • Gallbladder non-visualization on HIDA is highly accurate for acute cholecystitis
    • Consider CT with IV contrast if HIDA is also negative to evaluate complications or alternative diagnoses 1
  2. If functional biliary pain is suspected (recurrent RUQ pain, no fever, normal labs):

    • Patient should meet Rome III criteria for functional biliary pain 3
    • Patient should NOT be having acute pain at time of study 3
    • HIDA with CCK stimulation to calculate gallbladder ejection fraction (GBEF)
    • GBEF <38% suggests functional gallbladder disorder 3
    • GBEF <30% may predict more severe disease and higher complication rates 1
  3. If bile duct pathology is suspected:

    • MRCP is superior to both ultrasound and HIDA, with 85-100% sensitivity for choledocholithiasis 1

Important Caveats and Pitfalls

False Negatives on HIDA

  • Abnormal liver function tests can cause non-visualization of the biliary tree, making HIDA non-diagnostic 2
  • In the presence of jaundice, HIDA is less reliable 2

HIDA Scan Limitations

  • Causes significant delays in surgical management: mean time to surgery increases by 14-28 hours when HIDA is added 5
  • In uncomplicated cases, the delay can be even more pronounced (28 hours longer) 5
  • HIDA is likely overutilized in the era of Tokyo Guidelines 2018, with one study showing it was unnecessary in 36.9% of patients 6

When to Skip HIDA

HIDA may be unnecessary when patients have:

  • Male gender, older age, RUQ tenderness, clinical Murphy's sign, and ultrasound findings suggestive of acute cholecystitis (wall thickening, distention) 6
  • These clinical and ultrasound features together have high predictive value without HIDA 6

Quantifying the Discordance

The practical answer to your question: In patients with negative ultrasound but continued clinical suspicion:

  • For acute cholecystitis: approximately 9-12% of cases will have positive HIDA after negative ultrasound (based on the sensitivity gap) 1, 2
  • For functional gallbladder disorder: HIDA with CCK will identify abnormal GBEF in a substantial but variable proportion of patients with normal ultrasound and biliary-type pain 3
  • The exact percentage depends heavily on patient selection and clinical criteria used

The key clinical point: HIDA scan is most valuable when ultrasound is negative/equivocal AND clinical suspicion remains high based on symptoms and presentation. However, given the delays it causes and modest specificity in some contexts, it should be used selectively rather than reflexively 4, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.